CordenPharma Products, Technologies, and Services
From APIs to Drug Products, CordenPharma globally supplies flexible solutions which span the entire pharmaceutical development path from R&D to Commercialization. The products, technologies and services offered are: Generic API Development and Manufacturing, Custom Synthesis for Peptide APIs from grams to multi-tons, Synthetic Phospholipids, Conjugates, Carbohydrates, Highly Potent APIs and Small Molecules.
CordenPharma’s offerings also encompass Drug Product Development and Manufacturing, including solid forms of Highly Potent Formulations, Oral & Sterile Cephalosporins & Penicillins, Oral & Sterile Oncology Drug Products, Parenterals, as well as Primary & Secondary Packaging, Pack Serialisation / 2D Matrix Coding, and Logistics support.
This is of course a brief overview of our wide breadth of capabilities – more detailed information can be found by visiting our website at www.cordenpharma.com“.
The Italian Plants
InItaly, CordenPharma owns 3 production sites: CordenPharma Caponago, located nearMilan, with 250 employees (acquired June 2009); CordenPharma Latina, located in Sermoneta, nearRome, with 600 employees (acquired May 2010); and Farchemia, located in Treviglio, nearBergamo, with 160 employees (acquired December 2012).
CordenPharma Caponago provides formulation and packaging of parenteral dosage forms, sterile emulsion technology, pre-filled syringes, distribution of clinical trial medication, and formulation development. Its core competencies include formulation, terminal sterilisation, inspection and packing of parenterals; filling of ampoules, vials and syringes in 10 – 200ml range; extended analytical and micro-biological tests, and stability studies.
CordenPharma Latina is a renowned manufacturer of oral and sterile dosage forms for Cephalosporins, Penicillins and cytotoxics. CordenPharma Latina offers a full range of development and packaging services, and has a fully-integrated infrastructure (solvent recovery, thermal oxidizer, waste water treatment plant).
Farchemia manufactures small molecule active pharmaceutical ingredients (APIs) and advanced intermediates for the pharmaceutical industry, with specific expertise in several cutting-edge new chemical technologies. Its core competencies are cGMP custom synthesis from lab to multi-ton scale; multi-step API process development, manufacturing and analytical development; and industrialization from feasibility to commercial scale.